Literature DB >> 31287712

Anatomic Risk Factors for Focal Cartilage Lesions in the Patella and Trochlea: A Case-Control Study.

Luiz Felipe Ambra1,2, Betina B Hinckel3, Elizabeth A Arendt4, Jack Farr5, Andreas H Gomoll6.   

Abstract

BACKGROUND: Focal cartilage lesions in the patellofemoral (PF) joint are common. Several studies correlated PF risk factors with PF instability, anterior knee pain, and PF arthritis; however, there is a lack of evidence correlating those factors to PF focal cartilage lesions.
PURPOSE: To evaluate the influence of the anatomic PF risk factors in patients with isolated focal PF cartilage lesions. STUDY
DESIGN: Cross-sectional study; Level of evidence, 3.
METHODS: Patients with isolated PF focal cartilage lesions were included in the cartilage lesion group, and patients with other pathologies and normal PF cartilage were included in the control group. Multiple PF risk factors were accessed on magnetic resonance imaging scans: patellar morphology (patellar width, patellar thickness, and patellar angle), trochlear morphology (trochlear sulcus angle, lateral condyle index, and trochlear sulcus depth), patellar height (Insall-Salvati ratio and Caton-Deschamps index), axial patellar positioning (patellar tilt, angle of Fulkerson), and quadriceps vector (tibial tuberosity-trochlear groove distance).
RESULTS: A total of 135 patients were included in the cartilage lesion group and 100 in the control group. As compared with the control group, the cartilage lesion group had a higher sulcus angle (P = .0007), lower trochlear sulcus depth (P < .0001), lower angle of Fulkerson (P < .0001), lower patellar width (P = .0003), and higher Insall-Salvati ratio (P < .0001). From the patients in the cartilage lesion group, 36% had trochlear dysplasia; 27.6%, patella alta; and 24.7%, abnormal patellar tilt. These parameters were more frequent in the cartilage lesion group (P < .0001). Trochlear lesions were more frequent in men, presented at an older age, and had fewer associated anatomic risk factors. Patellar lesions, conversely, were more frequent in women, presented at younger age, and were more closely associated with anatomic risk factors.
CONCLUSION: PF anatomic abnormalities are significantly more common in patients with full-thickness PF cartilage lesions. Trochlear dysplasia, patella alta, and excessive lateral patellar tilt are the most common correlated factors, especially in patellar lesions.

Entities:  

Keywords:  anatomic risk factors; cartilage lesions; cartilage repair; cartilage restoration; patellofemoral; patellofemoral risk factors

Mesh:

Year:  2019        PMID: 31287712     DOI: 10.1177/0363546519859320

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  12 in total

1.  Combined distal femoral osteotomy and tibial tuberosity distalization is effective in patients presenting with patellar instability and patellofemoral pain due to patella alta and femoral malalignment.

Authors:  Julian Fluegel; Felix Zimmermann; Sebastian Gebhardt; Danko Dan Milinkovic; Peter Balcarek
Journal:  Arch Orthop Trauma Surg       Date:  2022-07-21       Impact factor: 2.928

2.  The SP-ET index is a new index for assessing the vertical position of patella.

Authors:  Jia Li; Mao Yuan; Lanyu Qiu; Bo Sheng; Fan Yu; Haitao Yang; Furong Lv; Fajin Lv; Wei Huang
Journal:  Insights Imaging       Date:  2022-09-24

3.  Increased femoral antetorsion correlates with higher degrees of lateral retropatellar cartilage degeneration, further accentuated in genu valgum.

Authors:  A Flury; A Hoch; O Andronic; B Fritz; F B Imhoff; S F Fucentese
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-12       Impact factor: 4.342

4.  Osteochondral Allograft Transplant of the Patella Using Femoral Condylar Allografts: Letter to the Editor.

Authors:  Adam B Yanke; Hailey P Huddleston; Blake M Bodendorfer
Journal:  Orthop J Sports Med       Date:  2021-04-30

5.  Relationship between Anatomical Risk Factors, Articular Cartilage Lesions, and Patient Outcomes Following Medial Patellofemoral Ligament Reconstruction.

Authors:  Charles L Holliday; Laurie A Hiemstra; Sarah Kerslake; John A Grant
Journal:  Cartilage       Date:  2019-12-26       Impact factor: 3.117

6.  An Expert Consensus Statement on the Management of Large Chondral and Osteochondral Defects in the Patellofemoral Joint.

Authors:  Jorge Chahla; Betina B Hinckel; Adam B Yanke; Jack Farr; William D Bugbee; James L Carey; Brian J Cole; Dennis C Crawford; James E Fleischli; Alan Getgood; Andreas H Gomoll; Simon Gortz; Allan E Gross; Deryk G Jones; Aaron J Krych; Christian Lattermann; Bert R Mandelbaum; Peter R Mandt; Tom Minas; Raffy Mirzayan; Timothy S Mologne; John D Polousky; Matthew T Provencher; Scott A Rodeo; Oleg Safir; Seth Lawrence Sherman; Eric D Strauss; Sabrina M Strickland; Christopher J Wahl; Riley J Williams
Journal:  Orthop J Sports Med       Date:  2020-03-26

7.  Tibial Tubercle Osteotomy With Distalization Is a Safe and Effective Procedure for Patients With Patella Alta and Patellar Instability.

Authors:  Chilan B G Leite; Társis P Santos; Pedro N Giglio; José R Pécora; Gilberto L Camanho; Riccardo G Gobbi
Journal:  Orthop J Sports Med       Date:  2021-01-21

8.  A study of the possible effect of abnormal patella height on meniscal tears.

Authors:  Themistoklis Vampertzis; Christina Barmpagianni; Georgios Nitis; Stergios Papastergiou
Journal:  J Orthop       Date:  2020-05-01

9.  A quantitative MRI investigation of the association between iliotibial band syndrome and patellofemoral malalignment.

Authors:  Jia Li; Bo Sheng; Lanyu Qiu; Fan Yu; Fa-Jin Lv; Fu-Rong Lv; Haitao Yang
Journal:  Quant Imaging Med Surg       Date:  2021-07

10.  Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation.

Authors:  Alexandre Barbieri Mestriner; Jakob Ackermann; Gergo Merkely; Pedro Henrique Schmidt Alves Ferreira Galvão; Luiz Felipe Morlin Ambra; Andreas H Gomoll
Journal:  Cartilage       Date:  2021-07-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.